Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Federica Brozzi in
Google Scholar
PubMed
Search for other papers by Pierina Santini in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
. 2008 Jun ; 37 ( 2 ): 457 – 80 . 10.1016/j.ecl.2008.02.007 18502337 0889-8529 5 Cherk MH , Kalff V , Yap KS , Bailey M , Topliss D , Kelly MJ . Incidence of radiation thyroiditis and thyroid remnant ablation success rates
Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed
Search for other papers by John M. Buatti in
Google Scholar
PubMed
Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed
Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed
Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed
Search for other papers by John M. Watkins in
Google Scholar
PubMed
not be indicated [ 7 , 8 ], and recent phase III trials have demonstrated equivalent rates of thyroid remnant ablation with 30 versus 100 mCi doses of RAI [ 9 , 10 ], practice patterns remain highly variable by individual practitioner [ 11 ]. The
Search for other papers by Nianting Ju in
Google Scholar
PubMed
Search for other papers by Liying Hou in
Google Scholar
PubMed
Search for other papers by Hongjun Song in
Google Scholar
PubMed
Search for other papers by Zhongling Qiu in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Zhenkui Sun in
Google Scholar
PubMed
Search for other papers by Quanyong Luo in
Google Scholar
PubMed
Search for other papers by Chentian Shen in
Google Scholar
PubMed
international literature, including many guidelines ( 6 , 7 , 8 ), as the minimum level of TSH stimulation for radioiodine therapy including thyroid remnant ablation. However, there is no definite evidence yet that TSH level ≥ 30 mU/L is necessary for
Search for other papers by Furio Pacini in
Google Scholar
PubMed
thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92:3542–3546. 10.1210/jc.2007-0225 17609306 5 Chianelli M, Todino V, Graziano FM, Panunzi C, Pace D, Guglielmi R, Signore A
Search for other papers by Fabián Pitoia in
Google Scholar
PubMed
Search for other papers by Erika Abelleira in
Google Scholar
PubMed
Search for other papers by Graciela Cross in
Google Scholar
PubMed
study, rhTSH in preparation for thyroid remnant ablation in patients with T4 primary tumors achieved a rate of ablation success that was not inferior to the rate after THW [ 21 ]. In a previous publication, we showed that rhTSH stimulation was associated
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
metastatic disease Activities of 1110 MBq are equally effective as higher activities for remnant ablation - If low-risk patients are referred for thyroid remnant ablation, activity of 1110 MBq should be considered as effective and safer than higher
Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Search for other papers by Maria Prado Talavera Rubio in
Google Scholar
PubMed
Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
differentiated thyroid cancer: a meta-analysis involving 3947 patients. J Clin Endocrinol Metab 2012; 97: 2754–2763. 28 Tamilia M, Al-Kahtani N, Rochon L, Hier MP, Payne RJ, Holcroft CA, et al: Serum thyroglobulin predicts thyroid remnant ablation failure
Search for other papers by Syed Ali Imran in
Google Scholar
PubMed
Search for other papers by Karen Chu in
Google Scholar
PubMed
Search for other papers by Murali Rajaraman in
Google Scholar
PubMed
Search for other papers by Drew Rajaraman in
Google Scholar
PubMed
Search for other papers by Sunita Ghosh in
Google Scholar
PubMed
Search for other papers by Sarah De Brabandere in
Google Scholar
PubMed
Search for other papers by Stephanie M. Kaiser in
Google Scholar
PubMed
Search for other papers by Stan Van Uum in
Google Scholar
PubMed
.1054/bjoc.2001.2173 11747326 0007-0920 21 Rachinsky I , Rajaraman M , Leslie WD , Zahedi A , Jefford C , McGibbon A , et al. Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
15943636 34 Karam M, Gianoukakis A, Feustel PJ, Cheema A, Postal ES, Cooper JA: Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl Med Commun 2003;24:489-495. 10.1097/00006231-200305000-00002 12717064 35
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Department of Nuclear Medicine, Irmandade Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil
Search for other papers by Rosália P. Padovani in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Search for other papers by Beatriz C.G. Freitas in
Google Scholar
PubMed
Search for other papers by Marilia M.S. Marone in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Cleber P. Camacho in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
]. Previous studies have attempted to demonstrate the benefits of RID by comparing the results of thyroid remnant ablation after RAI treatment in groups of patients who do and do not adhere to an RID [ 12 , 14 ]. However, considering that the efficacy of